Cargando…
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab
Provision of high-level healthcare is a challenge for all low- to middle-income countries (LMICs) since healthcare systems are heterogeneous, face many challenges such as inadequate funding, inequitable distribution of resources and services and usually are not adequately equipped to deal with a hug...
Autores principales: | Barrios, Carlos Henrique, Reinert, Tomás, Werutsky, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372298/ https://www.ncbi.nlm.nih.gov/pubmed/30792815 http://dx.doi.org/10.3332/ecancer.2019.898 |
Ejemplares similares
-
Estimation of the Number of Brazilian Women Living With Metastatic Breast Cancer
por: Reinert, Tomás, et al.
Publicado: (2020) -
Locally advanced breast cancer in Brazil: current status and future perspectives
por: Werutsky, Gustavo, et al.
Publicado: (2019) -
Mentoring as an opportunity to improve research and cancer care in Latin America (AAZPIRE project)
por: Angel, Martín Osvaldo, et al.
Publicado: (2020) -
Cost-effectiveness of breast, lung, colon, prostate and cervical cancer outcomes in Brazil: a worldwide comparison
por: Pellegrini, Rodrigo, et al.
Publicado: (2021) -
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
por: Gössling, Gustavo, et al.
Publicado: (2023)